Cargando…
Is there antibody-dependent enhancement in SARS Coronavirus 2?
Autores principales: | Kumar, Rohit, Gupta, Nitin, Kodan, Parul, Mittal, Ankit, Soneja, Manish, Wig, Naveet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380762/ https://www.ncbi.nlm.nih.gov/pubmed/32754556 http://dx.doi.org/10.4103/jfmpc.jfmpc_540_20 |
Ejemplares similares
-
Battling COVID-19: using old weapons for a new enemy
por: Kumar, Rohit, et al.
Publicado: (2020) -
Outcomes associated with standardized treatment regimens for extensively drug-resistant tuberculosis
por: Aggarwal, Anivita, et al.
Publicado: (2020) -
Lyme arthritis: A prospective study from India
por: Gupta, Nitin, et al.
Publicado: (2019) -
Role of Voriconazole in the Management of Invasive Central Nervous System Aspergillosis: A Case Series from a Tertiary Care Centre in India
por: Gupta, Nitin, et al.
Publicado: (2020) -
Nontuberculous mycobacteria: A report of eighteen cases from a tertiary care center in India
por: Gupta, Nitin, et al.
Publicado: (2020)